ImetelChat

FOSTER CITY, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective February 17, 2026, it granted stock options to purchase an aggregate of 742,500 shares of common stock to one newly hired employee as an inducement material to such employee’s acceptance of employment with Geron

Jay, something we should know? It’s for a “newly hired employee”. As for the “relatively” new CEO, he already has millions of options and I am sure he wants to show us he deserves them.

CEO already has quite a few GERN shares as part of his hiring plan.

Geron is still hiring.

Don’t look too deeply into the amount of shares offered, unless those shares are exercisable tomorrow—and they aren’t.